Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Neoplasms × Hematologic Tests × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 14 Lung Neoplasms 10 Colorectal Neoplasms 8 Prostatic Neoplasms 7 Breast Neoplasms 7 Stomach Neoplasms 3 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Neoplasm Metastasis 3 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Smoking Cessation 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic cancer, adult 2 Ovarian Neoplasms 2 Motor Activity 2 Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Wilms Tumor 1 Venous Thromboembolism 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Testicular Germ Cell Tumor 1 Stroke 1 Skin Neoplasms 1

Interventions

aldesleukin 39 Sunitinib 36 Cyclophosphamide 29 Nivolumab 28 pembrolizumab 26 Interferon-alpha 25 Everolimus 24 Sorafenib 21 Bevacizumab 20 fludarabine phosphate 19 Ipilimumab 17 Interleukin-2 17 Radiotherapy 16 Peripheral Blood Stem Cell Transplantation 15 Gene Expression Profiling 15 Gemcitabine 15 Filgrastim 15 Axitinib 15 cabozantinib 13 Radiosurgery 12 Blood Specimen Collection 11 temsirolimus 10 fludarabine 10 Doxorubicin 10 Carboplatin 10 sargramostim 8 belzutifan 8 Immunohistochemistry 8 Fluorouracil 8 Etoposide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04113486 2020-11-24

ENRC

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡